Skip to content

The Effects of Acupuncture for Major Trauma

The Effects of Electroacupuncture and Laser Acupuncture Therapy for Patients With Major Trauma

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04970433
Enrollment
180
Registered
2021-07-21
Start date
2021-10-12
Completion date
2024-07-31
Last updated
2022-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Trauma

Keywords

major trauma, acupuncture, laser acupuncture

Brief summary

Major trauma is a significant cause for morbidity and mortality in the world. After traumatic injury, the damage tissue could induce systemic inflammatory response (SIRS) and activate autonomic nervous system in response to stress, followed by compensatory anti-inflammatory response (CARS). Imbalance of SIRS and CARS may lead to organ failures, sepsis and death.

Detailed description

The investigators design a prospective clinical trial to investigate the efficacy of acupuncture for major trauma.

Interventions

Acupuncture at Hegu (LI4), Neiguan (PC6), Zusanli (ST36), Sanyinjiao (SP6) and Sishencong (EX-HN1). Electrical stimulation with a pair of electrodes connecting on LI4/PC6 and ST36/SP6.

The laser applies to each point for 40 seconds, which delivers 3 J of energy at each of the acupoints as those in electroacupuncture group.

The laser device without any laser output applies on the acupoints the same as those in the LA group.

Sponsors

Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female aged 20 years or older * Confirmed diagnosis of major trauma with ISS ≥ 16

Exclusion criteria

* Pregnancy * Malignancy * Pacemaker * Status epilepticus * Severe medical disease * Life threatening * Prior history of drug or alcohol dependence * Immunodeficiency * Vagotomy

Design outcomes

Primary

MeasureTime frameDescription
Length of hospital stayup to 24 weeksCount the total days of hospitalization

Secondary

MeasureTime frameDescription
IL-6measured at 48 hours, 7 days and 14 daysInflammatory mediator, IL-6
TNF-αmeasured at 48 hours, 7 days and 14 daysInflammatory mediator, TNF-α
IL-1βmeasured at 48 hours, 7 days and 14 daysInflammatory mediator, IL-1β
CRPmeasured at 48 hours, 7 days and 14 daysInflammatory mediator, CRP
Sequential organ failure assessment (SOFA) scoremeasured at 48 hours, 7 days and 14 daysThe SOFA score is a simple and objective score that allows for calculation of both the number and the severity of organ dysfunction in six organ systems (respiratory, coagulatory, liver, cardiovascular, renal, and neurologic), and the score can measure individual or aggregate organ dysfunction.The SOFA score ranges from 0 to 24; higher scores mean a worse outcome.
WHO Disability Assessment Schedule 2.0 (WHODAS 2.0) 12-item versionmeasured at 3 and 6 monthsWHODAS 2.0 is used to measure of disability after major trauma.
Peripheral Blood Mononuclear Cell (PBMC) analysismeasured at 48 hours, 7 days and 14 daysPBMC analysis by flow cytometry
IL-10measured at 48 hours, 7 days and 14 daysInflammatory mediator, IL-10

Countries

Taiwan

Contacts

Primary ContactChun-Ting Liu, Dr.
juntin0214@gmail.com0773171232334

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026